FAQ/Help |
Calendar |
Search |
Today's Posts |
![]() |
|
ALS News & Research For postings of news or research links and articles related to ALS |
|
Thread Tools | Display Modes |
![]() |
#1 | |||
|
||||
Grand Magnate
|
Neuraltus NP001 Phase 2 Trial: Targeting Neuroinflammation to Slow ALS Progression
ALS Trials | ALS Clinical Research | Neuraltus NP 1 Phase 2 Trial: Targeting Neuroinflammation to Slow ALS Progression | Educational Webinars | For People with ALS & Caregivers | Northeast Amyotrophic Lateral Sclerosis (ALS) Consortium |
|||
![]() |
![]() |
|
|
![]() |
||||
Thread | Forum | |||
Neuraltus Enrolls Nearly Half of Patients in Phase 2 Confirmation Trial of NP001 for | ALS News & Research | |||
Neuraltus Pharmaceuticals Provides Enrollment Update on Confirmatory Phase 2 Study of | ALS News & Research | |||
Neuraltus Pharmaceuticals Initiates Confirmatory Phase 2 Study of NP001 in Patients w | ALS News & Research | |||
Neuraltus Pharmaceuticals Announces Plans 2nd Phase 2 Study of NP001 in ALS . . . | ALS News & Research | |||
First human dosed in Phase 1 trial of antibody targeting alpha synuclein | Parkinson's Disease |